BlackRock Health Sciences Trust said on April 3, 2023 that its board of directors declared a regular monthly dividend of $0.21 per share ($2.56 annualized). Previously, the company paid $0.21 per share.

Shares must be purchased before the ex-div date of April 13, 2023 to qualify for the dividend. Shareholders of record as of April 14, 2023 will receive the payment on April 28, 2023.

At the current share price of $41.62 / share, the stock’s dividend yield is 6.14%. Looking back five years and taking a sample every week, the average dividend yield has been 5.85%, the lowest has been 4.84%, and the highest has been 8.66%. The standard deviation of yields is 0.58 (n=196).

The current dividend yield is 0.50 standard deviations above the historical average.

The company’s 3-Year dividend growth rate is 0.07%, demonstrating that it has increased its dividend over time.

Learn to Harvest Dividends

Buy Stock. Capture Dividend. Sell Stock. Repeat. This is the essence of dividend harvesting and you can do it easily with Fintel’s Dividend Capture Calendar.

What is the Fund Sentiment?

There are 72 funds or institutions reporting positions in BlackRock Health Sciences Trust. This is an increase of 10 owner(s) or 16.13% in the last quarter. Average portfolio weight of all funds dedicated to BME is 0.25%, a decrease of 10.01%. Total shares owned by institutions increased in the last three months by 9.73% to 2,521K shares.

What are Other Shareholders Doing?

© Provided by Fintel BME / BlackRock Health Sciences Trust Shares Held by Institutions

Elequin Capital holds 2K shares.

Wells Fargo holds 371K shares. No change in the last quarter.

Eudaimonia Partners holds 9K shares. In it’s prior filing, the firm reported owning 9K shares, representing an increase of 0.11%. The firm increased its portfolio allocation in BME by 5.72% over the last quarter.

Advisor Group Holdings holds 90K shares. In it’s prior filing, the firm reported owning 50K shares, representing an increase of 44.97%. The firm decreased its portfolio allocation in BME by 72.86% over the last quarter.

Semus Wealth Partners holds 13K shares.

BlackRock Health Sciences Trust Background Information

(This description is provided by the company.)

BlackRock Health Sciences Trust’s (BME) (the ‘Trust’) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust utilizes an option writing (selling) strategy to enhance dividend yield.

This story originally appeared on Fintel.